During the past decade, UOC Immunologia Clinica B-PGRM Centro di Riferimento per la Sclerosi Sistemica conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "UOC Immunologia Clinica B-PGRM Centro di Riferimento per la Sclerosi Sistemica" are "Pulmonary Arterial Hypertension" (2 trials). Many other conditions were trialed in "UOC Immunologia Clinica B-PGRM Centro di Riferimento per la Sclerosi Sistemica" in a lesser frequency.

Most popular intervention types in "UOC Immunologia Clinica B-PGRM Centro di Riferimento per la Sclerosi Sistemica" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Macitentan" (2 trials). Other intervention names were less common.

The vast majority of trials in "UOC Immunologia Clinica B-PGRM Centro di Riferimento per la Sclerosi Sistemica" are 2 trials for "All" genders.

Currently, there are NaN active trials in "UOC Immunologia Clinica B-PGRM Centro di Riferimento per la Sclerosi Sistemica". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in UOC Immunologia Clinica B-PGRM Centro di Riferimento per la Sclerosi Sistemica, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UOC Immunologia Clinica B-PGRM Centro di Riferimento per la Sclerosi Sistemica, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".